The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer.
S. A. Carp
No relevant relationships to disclose
C. Wanyo
No relevant relationships to disclose
M. Specht
No relevant relationships to disclose
L. Schapira
No relevant relationships to disclose
B. Moy
No relevant relationships to disclose
D. Finkelstein
No relevant relationships to disclose
D. Boas
No relevant relationships to disclose
S. J. Isakoff
No relevant relationships to disclose